Healthpeak Properties reported fourth-quarter funds from operations (FFO) of $0.47 per share, surpassing consensus estimates of $0.46 and marking a 2.2% year-over-year increase from $0.46 in Q4 2024. The company attributed the beat to same-store net operating income growth driven by rent escalators in its life science and industrial portfolios, as well as improved occupancy at medical office buildings. Revenue growth outpaced operating expenses, helping push the FFO margin higher despite inflationary pressure on property maintenance and labor costs.

Healthpeak progressed with its plan to spin off senior housing assets into a standalone real estate investment trust, Janus Living, transferring approximately $4.5 billion in gross assets. This realignment is expected to simplify the company’s structure and allow management to focus on higher-growth segments such as life science and medical office. The spin-off is slated for mid-2026 and aims to unlock value by establishing pure-play platforms with dedicated capital allocation frameworks and targeted balance-sheet strategies.

Despite an attractive 7% dividend yield and coverage ratios above 1.5x, an analyst downgraded the rating to HOLD, citing a 15–20% discount to net asset value, underperformance relative to the VNQ REIT index by nearly 60% since 2019, and a dual-CEO, externally managed structure that may exacerbate execution risk. The critique emphasized that targeted FFO growth remains unmet and that poor capital allocation—evidenced by stalled development returns—could pressure total returns if market conditions deteriorate.